Teltow, July 28, 2005. In its first half-year of 2005, the medical technology company SOMATEX® achieved a record result. SOMATEX® increased its overall turnover in sales of disposable minimum invasive instruments by 15.5 percent compared to the same period in 2004. This result has been primarily achieved due to a positive development in foreign trade and in sales of vertebroplasty products. Export turnover increased by a total of 22 percent thanks to a doubling of sales in Eastern Europe. Sales of products for vertebroplasty - i.e. the stabilization of damaged vertebral bodies using bone cement - increased by 70 percent.
In reaction to the excellent business figures, Frank Kniep, General Manager of SOMATEX, announced that SOMATEX® will extend its activities and plans to export its products to Russia, China and the United States. The approval processes for these countries are already under way.
According to SOMATEX, the positive results of the first half-year of 2005 also reflect customer confidence: ”The figures demonstrate that our customers are very satisfied with the quality of SOMATEX® products and with our ability to supply”, says Frank Kniep.
Information on SOMATEX®
The company SOMATEX® Medical Technologies GmbH specializes in the development and manufacturing of disposable minimally invasive instruments in the areas of tumor ablation, vertebroplasty, biopsy and oncology.
In addition to the manufacturing of standard instruments for diagnostic and therapeutical procedures, SOMATEX® develops innovative special products and new instruments based on what treating physicians precisely need. Since 1992, the company constantly develops new medical therapy concepts and realizes them in their products in close cooperation with physicians, hospitals and university clinics. Its focus is set on methods and instruments allowing minimally invasive operations using magnetic resonance imaging. In the past few years, the SOMATEX® has also intensified its activities aiming at the development of new procedures and instruments used to treat painful vertebral compression fractures, for example caused by osteoporosis.
No fees to be paid for publication. Please send specimen copy to:
Press Contact
unlimited communications berlin
Mr. Torsten Krüger
Rosenthalerstr. 40/41
D-10178 Berlin
Tel. 030 / 280078-63
E-Mail: tkrueger@ucm.de
Contact SOMATEX
SOMATEX Medical Technologies GmbH
Ms. Anja Schlicht
Rheinstr. 7d
D-14513 Teltow
Tel +49 (0) 3328 / 30 76-12
E-Mail: a.schlicht@SOMATEX.com
|
TELL A FRIEND
PRINTVIEW